CATALYSTEM™
-
Recon
First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
September 18, 2024, Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed…
Read More » -
Recon
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
Engineered for precision, confidence and efficiency in surgery – and compatible with the CORI◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global…
Read More »